Receive our newsletter – data, insights and analysis delivered to you
  1. Uncategorised
March 17, 2021

Coronavirus company news summary – Breathonix develops one-minute Covid-19 breath test – Roche launches SARS-CoV-2 variant test

By Chloe Kent

Breathonix, a spin-off company from the National University of Singapore (NUS), has developed a rapid breath test that can detect the SARS-CoV-2 virus within a minute. A joint trial between Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU), Dubai Health Authority (DHA), and Breathonix, is taking place in Dubai. The company’s initial pilot study in 180 patients achieved a sensitivity of 93% and specificity of 95% with the machine learning algorithm.

University of Rhode researchers have developed a new Covid-19 saliva test that will be used across its campuses for screening and surveillance of the SARS-CoV-2 virus. The test is less invasive than other nasal swab tests, is both specific and sensitive, and can deliver results at lower costs.

Roche has announced the launch of the cobas SARS-CoV-2 Variant Set 1 test which detects and differentiates mutations that were found in Covid variants across the UK, Brazil, and South Africa. The research use laboratory test is expected to help scientists in tracking mutations and analysing the impact on vaccines, diagnostics, and therapeutics.

Related Companies

Content from our partners
Precision wire: The future of bespoke medical treatment
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
“This technique means everything to us”: How CGM devices empower users 
Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU